Beth Israel Cancer Center

New York, New York 10003

0 studies enrolling now · 5 studies all time

What they study most

Cancer Cachexia, Ductal Adrenocarcinoma, Exocrine Pancreatic Cancer, Fatigue, Metastatic Androgen Independent Prostate Cancer, Neoplasms, Pancreatic Cancer, Prostate Cancer

Studies at this site

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine — Completed
• Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients — Completed